Moore Adam J, Mangou Khadidiatou, Diallo Fatoumata, Sene Seynabou D, Pouye Mariama N, Sadio Bacary D, Faye Ousmane, Mbengue Alassane, Bei Amy K
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
G4-Malaria Experimental Genetic Approaches & Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
Sci Rep. 2021 Jan 26;11(1):2225. doi: 10.1038/s41598-021-81711-9.
The PfRh5-Basigin ligand-receptor interaction is an essential step in the merozoite invasion process and represents an attractive vaccine target. To reveal genotype-phenotype associations between naturally occurring allelic variants of PfRh5 and invasion inhibition, we performed ex vivo invasion inhibition assays with monoclonal antibodies targeting basigin coupled with PfRh5 next-generation amplicon sequencing. We found dose-dependent inhibition of invasion across all isolates tested, and no statistically significant difference in invasion inhibition for any single nucleotide polymorphisms. This study demonstrates that PfRh5 remains highly conserved and functionally essential, even in a highly endemic setting, supporting continued development as a strain-transcendent malaria vaccine target.
PfRh5-疟原虫结合素配体-受体相互作用是裂殖子入侵过程中的关键步骤,也是一个有吸引力的疫苗靶点。为了揭示PfRh5自然发生的等位基因变体与入侵抑制之间的基因型-表型关联,我们使用靶向疟原虫结合素的单克隆抗体结合PfRh5下一代扩增子测序进行了体外入侵抑制试验。我们发现,在所有测试的分离株中均存在剂量依赖性的入侵抑制,且任何单核苷酸多态性的入侵抑制均无统计学显著差异。这项研究表明,即使在高度流行的环境中,PfRh5仍高度保守且在功能上至关重要,这支持了其作为一种超越菌株的疟疾疫苗靶点的持续开发。